Clinical Trial Update: A Study of Gemcitabine and Carboplatin (Plus Herceptin in Human Epidermal Growth Factor Receptor 2 Positive [HER2+] Patients) With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating gemcitabine and carboplatin with Herceptin in HER2-positive metastatic breast cancer has completed enrollment and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Gemzar (gemcitabine)
• HERCEPTIN (trastuzumab)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2009-11-17